Aspirin protect 300 mg gastrorezistentne tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aspirin protect 300 mg gastrorezistentne tablete

bayer d.o.o. - acetilsalicilna kislina - gastrorezistentna tableta - acetilsalicilna kislina 300 mg / 1 tableta - acetilsalicilna kislina

Aspirin plus C 400 mg/240 mg šumeče tablete z okusom pomaranče Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aspirin plus c 400 mg/240 mg šumeče tablete z okusom pomaranče

bayer d.o.o. - acetilsalicilna kislina; askorbinska kislina (vitamin c) - šumeča tableta - acetilsalicilna kislina 400 mg / 1 tableta  askorbinska kislina (vitamin c)240 mg / 1 tableta; askorbinska kislina (vitamin c) 240 mg / 1 tableta - acetilsalicilna kislina, kombinacije brez psiholeptikov

Aspirin 500 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aspirin 500 mg tablete

bayer d.o.o. - acetilsalicilna kislina - tableta - acetilsalicilna kislina 500 mg / 1 tableta - acetilsalicilna kislina

Aspirin plus C 400 mg/240 mg šumeče tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aspirin plus c 400 mg/240 mg šumeče tablete

bayer d.o.o. - acetilsalicilna kislina; askorbinska kislina (vitamin c) - šumeča tableta - acetilsalicilna kislina 400 mg / 1 tableta  askorbinska kislina (vitamin c)240 mg / 1 tableta; askorbinska kislina (vitamin c) 240 mg / 1 tableta - acetilsalicilna kislina, kombinacije brez psiholeptikov

Jentadueto Evropska unija - slovenščina - EMA (European Medicines Agency)

jentadueto

boehringer ingelheim international gmbh - linagliptin, metformin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zdravljenje odraslih bolnikov z tipa 2 sladkorna bolezen:jentadueto je indicirano kot dodatek k dieti in telesni za izboljšanje glycaemic nadzor pri odraslih bolnikih, neustrezno nadzorovano na maksimalno dopustne odmerek metforminom sam, ali tistih, ki se že zdravijo z kombinacijo linagliptin in metforminom. jentadueto je navedeno v kombinaciji z sulfonil sečnine (i. trojna kombinacija terapija), kot dopolnilo prehrane in vadbe pri odraslih bolnikih, neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine.

Vipdomet Evropska unija - slovenščina - EMA (European Medicines Agency)

vipdomet

takeda pharma a/s - alogliptin benzoata, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. trojna kombinacija terapija), kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor pri bolnikih, pri insulina na stabilen odmerek in metforminom sam ne zagotavljajo ustrezne glycaemic nadzor.

Eprocliv 50 mg/1000 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eprocliv 50 mg/1000 mg filmsko obložene tablete

metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Maymetsi 50 mg/850 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

maymetsi 50 mg/850 mg filmsko obložene tablete

metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Maymetsi 50 mg/850 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

maymetsi 50 mg/850 mg filmsko obložene tablete

metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Sitagliptin / Metformin hydrochloride Mylan Evropska unija - slovenščina - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.